Hospira Recalls Metoclopramide Injection Due to Glass Particulate Matter
Hospira Inc. is recalling 251,400 vials of Metoclopramide Injection because glass spicules were found during a site inspection.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a structural defect (glass spicules) in an injectable drug, which poses a significant risk of injury upon administration.
Plain-English summary
Hospira Inc. is recalling 251,400 vials of Metoclopramide Injection, USP 10 mg (5mg/mL), 2 mL Single-dose Vial. The product is identified by NDC 0409-3414-01 and Lot # 28-104-DK*, with an expiration date of 10/01/2014. The recall was initiated due to the presence of particulate matter, specifically glass spicules (glass strands), which were identified during a site inspection of the vials.
The affected product was distributed nationwide and in Puerto Rico. This is a prescription-only sterile injection intended for intramuscular or intravenous use. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Healthcare providers and patients should stop using the affected vials immediately. Consumers should check their medication for the specific lot number and expiration date listed above. If the product matches the recalled lot, it should be returned to the pharmacy or healthcare provider for disposal or replacement.
The recalled product
- Product
- METOCLOPRAMIDE (METOCLOPRAMIDE)
- Brand
- METOCLOPRAMIDE
- Manufacturer
- Hospira Inc.
- Affected units
- 251,400
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 28-104-DK*
- Exp 10/01/2014 (* lot number may be proceeded with an 01)
Distribution
Part of a larger recall action
This product is one of 2 recalled by Hospira Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · METOCLOPRAMIDE
- SevereMetoclopramide Tablets Recalled for Presence of Foreign Tablets
FDA (Drugs) · 2025-07-02
- SevereMetoclopramide Injection Vials Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-08-25
- SevereTeva Recalls Metoclopramide Injection Due to Sterility Concerns
FDA (Drugs) · 2021-05-26
- HighTeva Recalls Metoclopramide Injection Due to Chemical Contamination
FDA (Drugs) · 2021-03-10
- SevereTeva Recalls Metoclopramide Injection Due to Sterility Concerns
FDA (Drugs) · 2021-03-03
Same manufacturer · Hospira Inc.
See all →- CriticalHospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
- ModerateHospira Recalls Minibore Extension Sets Due to Solvent Occlusion
FDA (Devices) · 2017-01-18
- LowHospira Recalls Lidocaine and Dextrose Injection for Stability Failures
FDA (Drugs) · 2016-12-14
- SevereHospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips
FDA (Drugs) · 2016-11-30
- HighHospira Symbiq Infusion Pump Recall for White Screen Safety Shutdown
FDA (Devices) · 2016-11-16
Same hazard · glass particulate
See all →- SevereTestosterone Pellet 200 mg Recalled for Glass Particulate Matter
FDA (Drugs) · 2025-05-14
- HighTestosterone Pellet 200 mg Recalled for Glass Particulate Matter
FDA (Drugs) · 2025-05-14
- HighProgesterone Injection Recalled for Glass Particulate Matter in Vials
FDA (Drugs) · 2024-08-07
- HighCyanocobalamin Injection Vials Recalled for Glass Particulate Contamination
FDA (Drugs) · 2024-07-24
- HighEye and Ear Dropper Recalled for Potential Glass Particulate Contamination
FDA (Devices) · 2023-06-21